TG THERAPEUTICS, INC. Treasury Stock, Shares, Acquired
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- TG THERAPEUTICS, INC. treasury stock, shares, acquired for the quarter ending 2025-12-31 was -270.00 shares.
- TG THERAPEUTICS, INC. treasury stock, shares, acquired for the quarter ending 2025-09-30 was 2.78M shares, a 2914.64% increase year-over-year.
- TG THERAPEUTICS, INC. treasury stock, shares, acquired for the quarter ending 2025-06-30 was 193.50K shares.
- TG THERAPEUTICS, INC. treasury stock, shares, acquired for the quarter ending 2025-03-31 was 199.97K shares.
- TG THERAPEUTICS, INC. treasury stock, shares, acquired for fiscal 2025 was 3.18M shares, a 872.38% increase from fiscal 2024.
- TG THERAPEUTICS, INC. treasury stock, shares, acquired for fiscal 2024 was 326.59K shares.
| Period end | Treasury Stock, Shares, Acquired 3 month | Treasury Stock, Shares, Acquired 12 month |
|---|---|---|
| 2025-12-31 | -270.00 shares derived: 10-K 12 month − 3 quarters · filed 2026-02-27 | 3.18M shares 10-K · filed 2026-02-27 |
| 2025-09-30 | 2.78M shares 10-Q · filed 2025-11-05 | |
| 2025-06-30 | 193.50K shares 10-Q · filed 2025-08-08 | |
| 2025-03-31 | 199.97K shares 10-Q · filed 2025-05-09 | |
| 2024-12-31 | 326.59K shares 10-K · filed 2026-02-27 | |
| 2024-09-30 | 92.30K shares 10-Q · filed 2024-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |